Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles

International Journal of Nanomedicine

Volumn 6, Issue 1, 2011, Pages 35-43

  Ghaffari, Solmaz ^a   Varshosaz, Jaleh ^a   Saadat, Afrooz ^b   Atyabi, Fatemeh ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amikacin; Antimicrobial effects; Pseudomonas aeruginosa; Solid lipid nanoparticles; Stability

Indexed keywords

AMIKACIN; SOLID LIPID NANOPARTICLE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIOSTASIS; CONTROLLED STUDY; DIFFUSION; DISPERSION; DRUG RELEASE; DRUG STABILITY; FERTILIZATION; FREEZE DRYING; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STORAGE TEMPERATURE; ZETA POTENTIAL;

AMIKACIN; ANTI-BACTERIAL AGENTS; CHOLESTEROL; DRUG STABILITY; FREEZE DRYING; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; TEMPERATURE;

PSEUDOMONAS AERUGINOSA;

EID: 79251488476     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S13671     Document Type: Article

References (20)

1. Bartal C, Danon A, Schlaeffer F, et al. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Am J Med. 2003;114(3):194-198.
2. Schiffelers R, Storm G, Bakker-Woudenberg I. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J Antimicrob Chemother. 2001;48(3):333-344.
3. Wilson JF, Davis AC, Tobin CM. Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment. J Antimicrob Chemother.2003;52(1):78-82.
4. Hammond LJ, Galdwell S, Campbell PW. Cystic fibrosis, intravenous antibiotics, and home therapy. J Pediatr Health Care. 1991;5(1): 24-30.
5. Shah S, Misra A. Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance. AAPS Pharm Sci Tech. 2004;5(4):e65.
6. Cullen AB, Cox CA, Hipp SJ, Wolfson MR, Shaffer TH. Intra-tracheal delivery strategy of gentamicin with partial liquid ventilation. Resp Med.1999;93(11):770-778.
7. Atyabi F, Talaie F, Dinarvand R. Thiolated chitosan nanoparticles as an oral delivery system for amikacin: in vitro and ex vivo evaluations. J Nanosci Nanotechnol. 2009;9(8):4593-4603.
8. Varshosaz J, Ghaffari S, Khoshayand MR, Atyabi F, Azarmi S, Kobarfard F. Development and optimization of amikacin solid lipid nanoparticles by central composite design. J Liposome Res. 2010;20(2): 97-104.
9. Barani H, Montazer M. A review on applications of liposomes in textile processing. J Liposome Res. 2008;18(3):249-262.
10. Muller H, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161-177.
11. Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X. Lecitin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm. 2006;327(1-2):153-159.
12. Sweetman SC, editor. The Complete Drug Reference. 35th ed. London, UK: Chicago Pharmaceutical Press (PhP); 2007.
13. Beaulac C, Sachetelli S, Lagace J. In vitro bactericidal efficacy of sub-MIC concentration of liposome encapsulated antibiotic against gram- negative and gram- positive bacteria. J Antimicrob Chemother.1998;41(1):35-41.
14. Gazori T, Khoshayand MR, Azizi E, Yazdizade P, Nomani A, Haririan I. Evalution of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimization, and in vitro characterization. Carbohyd Polym. 2009;77(3):599-606.
15. Varshosaz J, Ghaffari S, Khoshayand MR, Atyabi F. Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design. Pharm Dev Tech. 2010; In press.
16. Vivek K, Reddy H, Murthy R. Investigation of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS Pharm Sci Tech.2007;8(4):16-24.
17. Larson TA, Peterson LR, Gerding DN. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms. J Clin Microbiol. 1985;22(5):819-821.
18. Siddiqi S, Heifets LB, Cynamon M. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol. 1993;31(9):2332-2338.
19. Bermudez LE, Wu M, Young LS. Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-incapsulated amikacin. J Infect Dis. 1987;156(3):510-513.
20. Poyner EA, Alpar HO, Almeida AJ, Gamble MD, Brown MRW. A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery. J Control Rel. 1995;35(1):41-48.